Skip to main content
. 2013 Aug 9;3(8):e003268. doi: 10.1136/bmjopen-2013-003268

Table 2.

Albumin-to-creatine ratio (ACR) by headache status and selection criterium

  Crude
Model I‡
Model II§
Mean ACR (95% CI) N p Value Mean ACR (95% CI) N p Value Mean ACR (95% CI) N p Value
Morbid sample 0.013* 0.13* 0.11*
 No headache 2.03 (1.92 to 2.14) 3998 1.96 (1.85 to 2.07) 3998 1.96 (1.85 to 2.06) 3978
 Non-migraine headache 1.95 (1.68 to 2.23) 591 0.61† 2.26 (1.97 to 2.54) 591 0.057† 2.27 (1.99 to 2.55) 585 0.044†
 Migraine 1.22 (0.68 to 1.75) 159 0.003† 1.85 (1.31 to 2.40) 159 0.70† 1.87 (1.33 to 2.41) 158 0.75†
Random sample 0.011* 0.60* 0.55*
 No headache 1.22 (1.11 to 1.32) 1289 1.16 (1.06 to 1.27) 1289 1.16 (1.05 to 1.26) 1285
 Non-migraine headache 0.96 (0.77 to 1.14) 418 0.017† 1.08 (0.89 to 1.26) 418 0.44† 1.07 (0.89 to 1.26) 417 0.44†
 Migraine 0.85 (0.53 to 1.16) 144 0.028† 1.02 (0.70 to 1.34) 144 0.41† 1.00 (0.68 to 1.31) 143 0.35†

*p Value for overall effect of headache groups.

†p Values are for comparison against no headache group within the same selection criterium.

‡Model I: adjusted for age and sex.

§Model II: adjusted for age, sex, self-reported diabetes and self-reported use of antihypertensive medication.